SourceOne Stock Info  Your one source site for stock research




Company Website

Investor Relations



What’s the buzz—

message boards


Market Watch

Money Central

Raging Bull

Board Central









Sepracor Inc



Sepracor Inc. is a research-based pharmaceutical company involved in the research, development and commercialization of different products that serve unmet medical needs. Sepracor’s compounds are either single isomer or active-metabolite forms of existing drugs or new chemical entity compounds that are unrelated to marketed products. Sepracor is developing products in two therapeutic areas: respiratory and central nervous system disorders. It has also licensed its technology and patent rights to third parties. These out-licensing agreements include Schering-Plough Corporation for CLARINEX, sanofi-aventis for ALLEGRA and UCB Pharma for XYZAL/XUSAL. Sepracor manufactures and sells XOPENEX Inhalation Solution, a short-acting bronchodilator, for the treatment or prevention of asthma.


Stock Quotes and Other Information





Silicon Investor



Market Watch

Clear Station



SourceOne Message Board


Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name














S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35